|
In rare cases, intestinal angioedema has been reported in post marketing experience. Hypotension: In clinical trials, adverse effects relating to hypotension occurred as follows: hypotension (1.4%), orthostatic hypotension (0.5%), other orthostatic effects (3.2%). In addition syncope occurred in 0.8% of patients. (See WARNINGS.) Cough: See PRECAUTIONS -Cough. Clinical Laboratory Test Findings Serum Electrolytes: (See PRECAUTIONS.) Text Continues Below

Creatinine, Blood Urea Nitrogen Minor reversible increases in blood urea nitrogen and serum creatinine were observed in patients with essential hypertension treated with ZESTORETIC. More marked increases have also been reported and were more likely to occur in patients with renal artery stenosis. (See PRECAUTIONS.) Serum Uric Acid, Glucose, Magnesium, Cholesterol, Triglycerides and Calcium: (See PRECAUTIONS). Hemoglobin and Hematocrit Small decreases in hemoglobin and hematocrit (mean decreases of approximately 0.5 g% and 1.5 vol%, respectively) occurred frequently in hypertensive patients treated with ZESTORETIC but were rarely of clinical importance unless another cause of anemia coexisted. In clinical trials, 0.4% of patients discontinued therapy due to anemia. Liver Function Tests Rarely, elevations of liver enzymes and/ or serum bilirubin have occurred. (See WARNINGS, Hepatic Failure.) Other adverse reactions that have been reported with the individual components are listed below: ZESTORETIC ® (Lisinopril and Hydrochlorothiazide) Lisinopril -In clinical trials adverse reactions which occurred with lisinopril were also seen with ZESTORETIC. In addition, and since lisinopril has been marketed, the following adverse reactions have been reported with lisinopril and should be considered potential adverse reactions for ZESTORETIC Body as a Whole Anaphylactoid reactions (see WARNINGS, Anaphylactoid Reactions During Membrane Exposure), malaise, edema, facial edema, pain, pelvic pain, flank pain, chills; Page: << Prev | 1 | 2 | 3 | 4 | 5 | Next >>
|